112 related articles for article (PubMed ID: 35356841)
1. Efficacy of siRNA-loaded nanoparticles in the treatment of K-RAS mutant lung cancer
Gencer A; Baysal I; Nemutlu E; Yabanoglu-Ciftci S; Arica B
J Microencapsul; 2022 May; 39(3):261-275. PubMed ID: 35356841
[TBL] [Abstract][Full Text] [Related]
2. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
Nagapoosanam AL; Ganesan N; Umapathy D; Moorthy RK; Arockiam AJV
Indian J Med Res; 2019 Mar; 149(3):345-353. PubMed ID: 31249199
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier.
d'Angelo I; Costabile G; Durantie E; Brocca P; Rondelli V; Russo A; Russo G; Miro A; Quaglia F; Petri-Fink A; Rothen-Rutishauser B; Ungaro F
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):170-181. PubMed ID: 29035132
[TBL] [Abstract][Full Text] [Related]
5. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
Lokras A; Foged C; Thakur A
Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
[TBL] [Abstract][Full Text] [Related]
6. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
8. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP
Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model.
Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G
Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309
[TBL] [Abstract][Full Text] [Related]
10. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable Film for the Targeted Delivery of siRNA-Loaded Nanoparticles to Vaginal Immune Cells.
Gu J; Yang S; Ho EA
Mol Pharm; 2015 Aug; 12(8):2889-903. PubMed ID: 26099315
[TBL] [Abstract][Full Text] [Related]
12. SiRNA drug delivery by biodegradable polymeric nanoparticles.
Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
[TBL] [Abstract][Full Text] [Related]
13. Distinct endocytosis and immune activation of poly(lactic-co-glycolic) acid nanoparticles prepared by single- and double-emulsion evaporation.
Pusch L; Brox R; Scheuer K; Yokosawa T; Wu M; Zubiri BA; Spiecker E; Jandt KD; Fischer D; Hackstein H
Nanomedicine (Lond); 2021 Oct; 16(23):2075-2094. PubMed ID: 34523349
[No Abstract] [Full Text] [Related]
14. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol.
Thanki K; Zeng X; Foged C
Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614
[TBL] [Abstract][Full Text] [Related]
15. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
[TBL] [Abstract][Full Text] [Related]
16. Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells.
Conte C; Monteiro PF; Gurnani P; Stolnik S; Ungaro F; Quaglia F; Clarke P; Grabowska A; Kavallaris M; Alexander C
Nanoscale; 2021 Jul; 13(26):11414-11426. PubMed ID: 34160534
[TBL] [Abstract][Full Text] [Related]
17. Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles.
Mehta A; Dalle Vedove E; Isert L; Merkel OM
Pharm Res; 2019 Jul; 36(9):133. PubMed ID: 31289919
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics.
Jeong SH; Jang JH; Lee YB
J Control Release; 2021 Jul; 335():86-102. PubMed ID: 34015399
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
20. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]